comparemela.com

Latest Breaking News On - Bank freiburg - Page 1 : comparemela.com

ITM Isotope Technologies Munich SE: ITM Signs Clinical Supply Agreement with Y-mAbs for n c a Lutetium-177

ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Y-mAbs' Targeted Radionuclide Therapy candidate GD2-SADA: 177Lu-DOTA Complex for GD2-positive solid

Valeria fisherBen orzelekSteffen schusterJulia hofmann susanne karlssonLu endolucinbetaCorporate communicationsY mabs therapeutics incTrophic communicationsDeutsche bank freiburgPharma solutions gmbY mab targeted radionuclide therapyTechnologies munichY mabs therapeuticsTargeted radionuclide therapyRadionuclide therapyBank freiburg

ITM Isotope Technologies Munich SE: ITM Provides n c a Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer

ITM to supply Advanced Accelerator Applications on an industrial scale with its high-quality n.c.a. lutetium-177 as core component of the newly approved radiotherapeutic, PluvictoTM ITM Isotope

Valeria fisherKostenloser wertpapierhandelBen orzelekSteffen schusterJulia hofmann susanne karlssonLu endolucinbetaUdoj vetterCorporate communicationsDrug administrationDistrict courtTrophic communicationsDeutsche bank freiburgAdvanced accelerator applicationsTechnologies munichChief executive officerTargeted radionuclide therapies

ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals

ICIF and Portland Holdings add to recently secured EUR 25 million equity investment from Grand Pharma, bringing the total in this financing round to EUR 58 million ITM Isotope Technologies Munich

Ben orzelekKeith matthewsValeria fisherKostenloser wertpapierhandelMichael lee chinSteffen schusterJulia hofmann susanne karlssonUdoj vetterIndigenous critical infrastructure fund canadaDistrict courtTrophic communicationsPortland holdingsCorporate communicationsIndigenous critical infrastructure fundDeutsche bank freiburgPortland investment counsel inc

ITM Isotope Technologies Munich SE: ITM to Support Educational Symposium on Multi-disciplinary Approaches to Personalized Medicine at the 2022 SNMMI Therapeutics Conference

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will support an industry-sponsored satellite symposium titled, "Multi-disciplinary Approach

United statesNew orleansFox chase cancer centerFox chaseSan franciscoBen orzelekThomas hopeNamrata vijayvergiaValeria fisherKostenloser wertpapierhandelSteffen schusterJulia hofmann susanne karlssonUdoj vetterUniversity of californiaDepartment of radiologyDistrict court

ITM to Support Educational Symposium on Multi-disciplinary Approaches to Personalized Medicine at the 2022 SNMMI Therapeutics Conference

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesNew orleansFox chase cancer centerFox chaseSan franciscoValeria fisherBen orzelekSteffen schusterJulia hofmann susanne karlssonUdoj vetterThomas hopeNamrata vijayvergiaUniversity of californiaDepartment of radiologyDistrict courtTrophic communications

vimarsana © 2020. All Rights Reserved.